Voyager Therapeutics, Inc. (VYGR)
3.41
+0.09
(+2.71%)
USD |
NASDAQ |
Jun 11, 12:28
Voyager Therapeutics EPS Diluted (TTM) : -1.978 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.978 |
| December 31, 2025 | -2.040 |
| September 30, 2025 | -2.170 |
| June 30, 2025 | -1.852 |
| March 31, 2025 | -1.458 |
| December 31, 2024 | -1.125 |
| September 30, 2024 | 0.7206 |
| June 30, 2024 | 0.2864 |
| March 31, 2024 | -0.0482 |
| December 31, 2023 | 3.092 |
| September 30, 2023 | 1.228 |
| June 30, 2023 | 2.264 |
| March 31, 2023 | 2.276 |
| December 31, 2022 | -1.226 |
| September 30, 2022 | -0.4623 |
| June 30, 2022 | -1.573 |
| March 31, 2022 | -1.876 |
| December 31, 2021 | -1.893 |
| September 30, 2021 | -2.471 |
| June 30, 2021 | 0.4666 |
| March 31, 2021 | 1.034 |
| December 31, 2020 | 0.9546 |
| September 30, 2020 | 1.040 |
| Date | Value |
|---|---|
| June 30, 2020 | -1.641 |
| March 31, 2020 | -1.112 |
| December 31, 2019 | -1.270 |
| September 30, 2019 | -1.626 |
| June 30, 2019 | -1.848 |
| March 31, 2019 | -2.942 |
| December 31, 2018 | -2.755 |
| September 30, 2018 | -2.458 |
| June 30, 2018 | -2.717 |
| March 31, 2018 | -2.647 |
| December 31, 2017 | -2.67 |
| September 30, 2017 | -2.84 |
| June 30, 2017 | -2.30 |
| March 31, 2017 | -1.94 |
| December 31, 2016 | -1.58 |
| September 30, 2016 | -1.68 |
| June 30, 2016 | -1.588 |
| March 31, 2016 | -1.47 |
| December 31, 2015 | -4.90 |
| September 30, 2015 | -4.23 |
| June 30, 2015 | -3.972 |
| March 31, 2015 | -3.72 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Neurocrine Biosciences, Inc. | 6.504 |
| Agenus, Inc. | 1.670 |
| Amgen, Inc. | 14.38 |
| BioCryst Pharmaceuticals, Inc. | -1.776 |
| Imunon, Inc. | -5.167 |